Jane Street Group, LLC Ocular Therapeutix, Inc Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$8.33 - $11.47 $116,620 - $160,580	14,000 Added 73.3%	33,100 $282,000
Q3 2024 Nov 14, 2024	BUY	$6.45 - $9.23 $123,195 - $176,293	19,100 New	19,100 $166,000
Q1 2022 May 17, 2022	SELL	$4.83 - $7.35 $109,158 - $166,110	-22,600 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$6.16 - $12.07 $129,360 - $253,470	-21,000 Reduced 48.17%	22,600 $158,000
Q3 2021 Nov 16, 2021	SELL	$9.7 - $14.34 $15,519 - $22,944	-1,600 Reduced 3.54%	43,600 $436,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $384,098 - $547,976	28,600 Added 172.29%	45,200 $641,000
Q4 2020 Feb 17, 2021	SELL	$7.91 - $22.95 $919,933 - $2.67 Million	-116,300 Reduced 87.51%	16,600 $344,000
Q2 2020 Aug 17, 2020	BUY	$4.67 - $8.95 $528,177 - $1.01 Million	113,100 Added 571.21%	132,900 $1.11 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $78,210 - $146,520	19,800 New	19,800 $98,000

186

136M

284K

156K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $560M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.